A Case of Infective Endocarditis Caused by Citrobacter koseri: Unraveling a Rare Pathogen and Dire Outcome
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 12
Abstract
Citrobacter koseri (formerly classified as Citrobacter diversus) is a gram-negative bacillus (GNB) that occurs as an opportunistic pathogen in neonates and immunocompromised patients. Citrobacter species have been implicated in nosocomial settings leading to infections involving the urinary tract, respiratory tract, liver, biliary tract, meninges, and even in rarer conditions—blood stream infection and infective endocarditis (IE). Gram-negative bacilli are responsible for 3% to 4% of all IE cases and have been traditionally associated with intravenous drug users. Patients with non-HACEK (species other than Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, or Kinglella species) GNB IE have poor clinical outcomes with higher rates of in-hospital mortality and complications. The American Heart Association (AHA) and Infectious Diseases Society of America (IDSA) both recommend the use of combination antibiotic therapy with a beta-lactam (penicillins, cephalosporins, or carbapenems) and either an aminoglycoside or fluoroquinolones for 6 weeks (about 1 and a half months) to treat IE due to non-HACEK GNB. Citrobacter koseri is becoming more recognized due to its inherent resistance to ampicillin and emerging drug resistance to beta lactams and aminoglycosides requiring carbapenem therapy. Our case is of a 75-year-old male with no previously reported history of primary or secondary immunodeficiency disorders who developed C koseri blood stream infection. His infectious work-up revealed mitral valve IE and septic cerebral emboli resulting in ischemic infarcts. This case illustrates the importance of recognizing GNB organisms as rising human pathogens in IE cases even without active injection drug use or nosocomial exposure.Keywords
This publication has 10 references indexed in Scilit:
- Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative InfectionsClinical Infectious Diseases, 2023
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsCirculation, 2015
- Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing EnterobacteriaceaeJournal of Clinical Microbiology, 2011
- Beyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible β-LactamasesThe Journal of Pediatric Pharmacology and Therapeutics, 2011
- Abscess Caused by Citrobacter koseri Infection: Three Case Reports and a Literature ReviewInternal Medicine, 2011
- Infective Endocarditis Due to Citrobacter koseri in an Immunocompetent AdultJournal of Clinical Microbiology, 2009
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Non-HACEK Gram-Negative Bacillus EndocarditisAnnals of Internal Medicine, 2007
- Citrobacter infections in a tertiary care hospital in Northern IndiaJournal of Infection, 2007
- Citrobacter koseri infection and abscess associated with Harrington rodsAmerican Journal of Infection Control, 2004